A synthetic peptide fragment of thymosin beta-4 (Ac-LKKTETQ). Contains the conserved actin-binding domain (LKKTET motif).
Mechanism:
- Binds G-actin โ prevents polymerization โ regulates cytoskeletal remodeling
- Promotes fibroblast migration & matrix remodeling (MMP-2, MMP-9)
- Modulates collagen deposition & wound closure
Key Nuance (2024 Study):
The metabolite Ac-LKKTE showed significant wound healing activity. The parent peptide did not. This suggests metabolites may be the active agents.
Research Applications:
- Tissue regeneration (muscle, tendon, ligament)
- Angiogenesis research (endothelial migration, tube formation)
- Wound healing models
Evidence Landscape:
- Largely preclinical (animal & in vitro)
- Limited human evidence, especially for musculoskeletal applications
- Single direct TB-500 study included in a 2026 scoping review
Status:
- Not FDA-approved
- Banned by WADA
- Research use only
Takeaway:
TB-500 influences fibroblast behavior & actin dynamics, but human evidence for musculoskeletal healing remains limited.
โ ๏ธ Research only. Not for human consumption.